Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherIMMUNOPHARMACOLOGY

Role of Corticosterone in the Enhancement of the Antibody Response after Acute Cocaine Administration

Eric D. Stanulis, Ray A. Matulka, Stephen D. Jordan, John A. Rosecrans and Michael P. Holsapple
Journal of Pharmacology and Experimental Therapeutics January 1997, 280 (1) 284-291;
Eric D. Stanulis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ray A. Matulka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen D. Jordan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John A. Rosecrans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael P. Holsapple
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

A model has been developed in which acute cocaine administration results in an enhanced T-dependent antibody response to sheep erythrocytes. This enhancement occurs when cocaine (30 mg/kg, twice in 1 day) is administered 1 or 2 days before sensitization with antigen, in mice older than 16 wk. Acute cocaine has been shown to elicit a rise in serum corticosterone, and the administration of exogenous corticosterone, under similar conditions as cocaine, also results in a similar immunoenhancement. Further evidence in support of a role by corticosterone is the lack of an enhancement in adrenalectomized mice and the ability of α-helical corticotropin releasing factor to block the enhancement by cocaine. The role of concomitant epinephrine release from the adrenal was addressed by adrenal demedullation. Eliminating epinephrine, but not corticosterone release, had no effect on the cocaine-induced immunoenhancement. The evidence presented provides support for a major role by corticosterone in mediating cocaine’s effects on at least one measure of immune function, the T-dependent antibody response.

Footnotes

  • Send reprint requests to: Dr. John Rosecrans, Professor, Department of Pharmacology and Toxicology, Medical College of Virginia/Virginia Commonwealth University, Box 980613 MCV Station, Richmond, VA 23298.

  • ↵1 This work was supported by National Institutes of Health Grant DA 08161 and by Training Grant ES 07087.

  • ↵2 Current address: Department of Environmental Health, Boston University School of Medicine, 80 East Concord St. S-105, Boston, MA 02118.

  • ↵3 Current address: Immunotoxicology Program, Toxicology Research Laboratory, 1803 Building, The Dow Chemical Company, Midland, MI 48674.

  • Abbreviations:
    HIV
    human immunodeficiency virus
    AIDS
    acquired immunodeficiency syndrome
    SRBC
    sheep red blood cells
    CRF
    corticotropin-releasing factor
    αh-CRF
    α-helical corticotropin-releasing factor[9–41]
    EBSS
    Earle’s balanced salt solution
    AFC
    antibody forming cells
    SPLC
    splenocytes
    HPA
    hypothalamic-pituitary-adrenal
    ADX
    adrenaletomy
    AMX
    adrenal demedullation
    ACTH
    corticotropin
    VH
    vehicle
    • Received May 7, 1996.
    • Accepted September 12, 1996.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 280, Issue 1
1 Jan 1997
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Role of Corticosterone in the Enhancement of the Antibody Response after Acute Cocaine Administration
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherIMMUNOPHARMACOLOGY

Role of Corticosterone in the Enhancement of the Antibody Response after Acute Cocaine Administration

Eric D. Stanulis, Ray A. Matulka, Stephen D. Jordan, John A. Rosecrans and Michael P. Holsapple
Journal of Pharmacology and Experimental Therapeutics January 1, 1997, 280 (1) 284-291;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherIMMUNOPHARMACOLOGY

Role of Corticosterone in the Enhancement of the Antibody Response after Acute Cocaine Administration

Eric D. Stanulis, Ray A. Matulka, Stephen D. Jordan, John A. Rosecrans and Michael P. Holsapple
Journal of Pharmacology and Experimental Therapeutics January 1, 1997, 280 (1) 284-291;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Spontaneous and Cationic Lipid-Mediated Uptake of Antisense Oligonucleotides in Human Monocytes and Lymphocytes
  • Modulation of Mouse Endotoxin Shock by Inhibition of Phosphatidylcholine-Specific Phospholipase C
  • IL-10 Synergizes with Dexamethasone in Inhibiting Human T Cell Proliferation
Show more IMMUNOPHARMACOLOGY

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics